US Market Report for Insulin Syringes 2017 - MedCore

  • ID: 3960387
  • Report
  • Region: United States
  • 56 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
The U.S. insulin syringe market can be segmented by syringe type, yielding two segments: conventional insulin syringes and safety insulin syringes. In 2016, the largest segment in the total insulin syringe market was the conventional insulin syringe segment. Although conventional insulin syringes were once a popular method of insulin delivery, patients are transitioning towards new technologies such as insulin pens and pumps. Unit sales will continue to decline over the forecast period in conjunction with the growing penetration rate of insulin pens, as well as the growing penetration rate of insulin pumps among the type 2 insulin-dependent patient population. Mild ASP depreciation will also contribute to erosion in the value of the conventional insulin syringe market.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Table Of Contents I
List Of Figures Iii
List Of Charts Iv
Executive Summary
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
Insulin Syringe Market
3.1 Introduction
3.2 Market Overview
3.3 Market Analysis And Forecast
3.3.1 Total Insulin Syringe Market
3.3.1.1 Conventional Insulin Syringe Market
3.3.1.2 Safety Insulin Syringe Market
3.4 Drivers And Limiters
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 Competitive Market Share Analysis
Abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Although many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, syringes are still the most widely used device to inject insulin. Insulin syringes are moving from being hypodermic to those with finer points. Syringes are used with 10 mL insulin vials and come in 0.3 mL, 0.5 mL and 1 mL calibrations. In addition, thinner and shorter syringes are becoming more popular in the market, as they cause less discomfort when giving an injection. Needle thickness is indicated by gauge number; the higher the gauge number, the thinner the needle.
Note: Product cover images may vary from those shown
5 of 5
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll